GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Biocon Ltd

Biocon Ltd: CTO resigns, new CTO appointed w.e.f. Jan 2027

MANAGEMENT ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 04 Nov 2026, 01:26 PM IST  ·  BSE ID: 6a249ea5-d0c4-4235-b7c3-f21d046e592b
View Original BSE Filing (PDF)
💡
In Simple Terms
Biocon's leadership is changing: its technology chief is leaving, and a new one will start next year.
🤖 AI Summary
  • Biocon board approved unaudited financial results for the quarter and half-year ended September 30, 2026.
  • Chief Technology Officer, Dr. Mandar Shrikant Ghatnekar, resigned effective December 31, 2026.
  • Mr. Mukesh Rathi appointed as Chief Technology Officer effective January 01, 2027.
  • Board meeting held on November 04, 2026, reviewed standalone and consolidated results.
🏢 How This Affects the Company
📈
Business Impact
The appointment of a new Chief Technology Officer may bring new strategic directions to the company's technology initiatives and innovation pipeline.
⚙️
Operational Impact
A change in a senior management role like CTO can lead to shifts in operational focus and technology deployment strategies.
⚠️
Risk Impact
Change in senior leadership, while a standard business event, introduces a period of transition that requires continuity in technology operations.
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders regarding this announcement.
👤
Who Is Affected
All shareholders are informed of the senior management changes and the approval of the financial results.
🔍
Management Signal
The board's approval of results and the structured transition of a senior role signal operational continuity and governance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 results announcement to review performance post-management change.
Future disclosures on technology strategy under new CTO.
Review of Q2 FY27 financial results for detailed performance insights.
LOW RISK Standard management changes and routine financial result disclosures.
💡 Investor Takeaway
Biocon's Board approved Q2 FY27 results. Dr. Mandar Shrikant Ghatnekar resigned as CTO effective December 31, 2026, to be succeeded by Mr. Mukesh Rathi on January 01, 2027.
❓ Frequently Asked Questions
What did Biocon's Board approve on November 04, 2026?
The Board approved the unaudited financial results for the quarter and half-year ended September 30, 2026.
Who is resigning as Chief Technology Officer at Biocon?
Dr. Mandar Shrikant Ghatnekar is resigning as Chief Technology Officer, with his last day being December 31, 2026.
Who is the new Chief Technology Officer at Biocon?
Mr. Mukesh Rathi has been appointed as the new Chief Technology Officer, effective January 01, 2027.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.